Functional effects of 13 Rare PRSS1 variants presumed to cause chronic pancreatitis

Gut

Volumn 63, Issue 2, 2014, Pages 337-343

  Schnúr, Andrea ^a,b   Beer, Sebastian ^a   Witt, Heiko ^c,d   Hegyi, Péter ^b   Sahin Tóth, Miklós ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; CHYMOTRYPSIN C; TRYPSINOGEN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CELL STRAIN HEK293; CELLULAR SECRETION; CHRONIC PANCREATITIS; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; MISSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN SECRETION; PRSS1 GENE;

EID: 84891681793     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-304331     Document Type: Article

References (27)

1. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14 141-5. (Pubitemid 26338792)
2. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2 252-61. (Pubitemid 38293313)
3. Teich N, Rosendahl J, Tóth M, et al. Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat 2006;27 721-30. (Pubitemid 44205064)
4. Rebours V, Boutron-Ruault MC, Schnee M, et al. The natural history of hereditary pancreatitis: a national series. Gut 2009;58 97-103.
5. Szmola R, Sahin-Tóth M. Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis- associated mutations. J Med Genet 2010;47 348-50.
6. Szabó A, Sahin-Tóth M. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C. J Biol Chem 2012;287 20701-10.
7. Nemoda Z, Sahin-Tóth M. Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen. J Biol Chem 2006;281 11879-86. (Pubitemid 43855449)
8. Szmola R, Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y. Proc Natl Acad Sci USA 2007;104 11227-32. (Pubitemid 47175123)
9. Kereszturi E, Szmola R, Kukor Z, et al. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism. Hum Mutat 2009;30 575-82.
10. Király O, Guan L, Szepessy E, et al. Expression of human cationic trypsinogen with an authentic N terminus using intein-mediated splicing in aminopeptidase P deficient Escherichia coli. Protein Expr Purif 2006;48 104-11. (Pubitemid 43782629)
11. Király O, Guan L, Sahin-Tóth M. Expression of recombinant proteins with uniform N-termini. Methods Mol Biol 2011;705 175-94.
12. Beer S, Zhou J, Szabó A, et al. Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk. Gut 2013;62 1616-24.
13. Szabó A, Héja D, Szakács D, et al. High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues. J Biol Chem 2011;286 22535-45.
14. Chen JM, Bis A Piepoli, LeBodic L, et al. Mutational screening of the cationic trypsinogen gene in a large cohort of subjects with idiopathic chronic pancreatitis. Clin Genet 2001;59 189-93. (Pubitemid 32229775)
15. Teich N, Bauer N, Mössner J, et al. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol 2002;97 341-6. (Pubitemid 34160759)
16. Chang YT, Wei SCm L P-C, et al. Association and differential role of PRSS1 and SPINK1 mutation in early-onset and late-onset idiopathic chronic pancreatitis in Chinese subjects. Gut 2009;58 885.
17. Zeng K, Liu QC, Lin JH, et al. Novel mutations of PRSS1 gene in patients with pancreatic cancer among Han population. Chin Med J (Engl) 2011;124 2065-7.
18. Lee YJ, Kim KM, Choi JH, et al. High incidence of PRSS1 and SPINK1 mutations in Korean children with acute recurrent and chronic pancreatitis. J Pediatr Gastroenterol Nutr 2011;52 478-81.
19. Szmola R, Sahin-Tóth M. Pancreatitis-associated chymotrypsinogen C (CTRC) mutant elicits endoplasmic reticulum stress in pancreatic acinar cells. Gut 2010;59 365-72.
20. Le Maréchal C, Masson E, Chen JM, et al. Hereditary pancreatitis caused by triplication of the trypsinogen locus. Nat Genet 2006;38 1372-4. (Pubitemid 44837557)
21. Masson E, Le Maréchal C, Chandak GR, etal. Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis. Clin Gastroenterol Hepatol 2008;6 82-8.
22. Whitcomb DC, Larusch J, Krasinskas AM, et al. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 2012;44 1349-54.
23. Keiles S, Kammesheidt A. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis. Pancreas 2006;33 221-7. (Pubitemid 44470135)
24. Tautermann G, Ruebsamen H, Beck M, etal. R116C mutation of cationic trypsinogen in a Turkish family with recurrent pancreatitis illustrates genetic microheterogeneity of hereditary pancreatitis. Digestion 2001;64 226-32. (Pubitemid 34158329)
25. Rosendahl J, Landt O, Bernadova J, etal. CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? Gut 2013;62 582-92.
26. Sultan M, Werlin S, Venkatasubramani N. Genetic prevalence and characteristics in children with recurrent pancreatitis. J Pediatr Gastroenterol Nutr 2012;54 645-50.
27. Corleto VD, Gambardella S, Gullotta F, et al. New PRSS1 and common CFTR mutations in a child with acute recurrent pancreatitis, could be considered an "Hereditary" form of pancreatitis? BMC Gastroenterol 2010;10 119.